-+ 0.00%
-+ 0.00%
-+ 0.00%

TherapeuticsMD Second Quarter 2025 Earnings: EPS: US$0.047 (vs US$0.091 loss in 2Q 2024)

Simply Wall St·08/18/2025 10:36:26
Listen to the news

TherapeuticsMD (NASDAQ:TXMD) Second Quarter 2025 Results

Key Financial Results

  • Net income: US$545.0k (up from US$1.05m loss in 2Q 2024).
  • EPS: US$0.047 (up from US$0.091 loss in 2Q 2024).
earnings-and-revenue-history
NasdaqGS:TXMD Earnings and Revenue History August 18th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

TherapeuticsMD shares are up 8.3% from a week ago.

Risk Analysis

Be aware that TherapeuticsMD is showing 2 warning signs in our investment analysis that you should know about...